We are live on
!
Find out more
GPCM
Granite Point Capital Management Portfolio holdings
AUM
$4.9M
1-Year Est. Return
38.41%
This Fund
S&P 500
This Quarter
Est. Return
+2.1%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
–
AUM
$125M
AUM Growth
-$131M
(-51%)
Cap. Flow
-$122M
Cap. Flow
% of AUM
-97.07%
Top 10 Holdings %
Top 10 Hldgs %
39.36%
Holding
112
New
21
Increased
21
Reduced
8
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$4.61M |
| 2 |
Axogen
AXGN
|
+$2.46M |
| 3 |
Aclaris Therapeutics
ACRS
|
+$2.42M |
| 4 |
Bank of America
BAC
|
+$2.41M |
| 5 |
HDSN
Hudson Technologies
HDSN
|
+$1.84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.91M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$4.02M |
| 3 |
HIMX
Himax Technologies
HIMX
|
+$3.25M |
| 4 |
CY
Cypress Semiconductor
CY
|
+$2.13M |
| 5 |
MEET
The Meet Group, Inc. Common Stock
MEET
|
+$1.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.12% |
| 2 | Consumer Discretionary | 12.52% |
| 3 | Technology | 11.2% |
| 4 | Communication Services | 9.58% |
| 5 | Financials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NORD
26
DELISTED
Nord Anglia Education, Inc.
NORD
| $1.63M | 1.3% |
70,000
+23,200
| +50% | +$526K |
|
|
NXTM
27
DELISTED
NxStage Medical Inc.
NXTM
| $1.58M | 1.26% |
60,250
| – | – |
|
28
WIX.com
WIX
$2.3B
| $1.51M | 1.21% |
34,000
+11,500
| +51% | +$519K |
|
|
SBBP
29
DELISTED
Strongbridge Biopharma plc.
SBBP
| $1.46M | 1.16% |
606,607
-98,874
| -14% | -$403K |
|
|
BWLD
30
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $1.39M | 1.11% |
9,000
| – | – |
|
|
HABT
31
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
| $1.38M | 1.1% |
+80,000
| New | +$1.23M |
|
32
Align Technology
ALGN
$12.1B
| $1.21M | 0.97% |
12,600
| – | – |
|
|
TSRO
33
DELISTED
TESARO, Inc.
TSRO
| $1.21M | 0.96% |
9,000
| – | – |
|
34
STMicroelectronics
STM
$46.7B
| $1.14M | 0.9% |
100,000
-174,300
| -64% | -$1.65M |
|
35
TAL Education Group
TAL
$6.93B
| $1.12M | 0.89% |
96,000
+36,000
| +60% | +$440K |
|
|
DERM
36
DELISTED
Dermira, Inc.
DERM
| $1.12M | 0.89% |
37,000
+10,000
| +37% | +$322K |
|
|
BEAT
37
DELISTED
BioTelemetry, Inc.
BEAT
| $1.11M | 0.89% |
49,746
| – | – |
|
38
Tyler Technologies
TYL
$12.7B
| $1.07M | 0.85% |
7,475
| – | – |
|
39
Altisource Portfolio Solutions
ASPS
$63.6M
| $1.06M | 0.85% |
5,000
+2,750
| +122% | +$613K |
|
|
CYBE
40
DELISTED
Cyberoptics Corp
CYBE
| $1.04M | 0.83% |
40,000
+30,000
| +300% | +$783K |
|
41
Summit Therapeutics
SMMT
$10.4B
| $1M | 0.8% |
117,113
+11,852
| +11% | +$126K |
|
|
DOC
42
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $973K | 0.78% |
51,300
| – | – |
|
43
MACOM Technology Solutions
MTSI
$19.2B
| $926K | 0.74% |
20,000
| – | – |
|
44
Good Times Restaurants
GTIM
$14.6M
| $899K | 0.72% |
285,300
| – | – |
|
45
Alibaba
BABA
$293B
| $878K | 0.7% |
10,000
+1,000
| +11% | +$96.3K |
|
|
EMKR
46
DELISTED
Emcore Corp
EMKR
| $870K | 0.69% |
+10,000
| New | +$688K |
|
47
Vipshop
VIPS
$7.37B
| $859K | 0.68% |
78,016
-50,000
| -39% | -$646K |
|
48
ZTO Express
ZTO
$18.3B
| $845K | 0.67% |
+70,000
| New | +$1.01M |
|
49
Baidu
BIDU
$37.7B
| $822K | 0.66% |
5,000
| – | – |
|
50
PTC Therapeutics
PTCT
$5.68B
| $818K | 0.65% |
+75,000
| New | +$787K |
|
Similar funds
MAM
CCM
BGCI
CAM
EAM
SM
TPL
RC
Granite Point Capital Management's Q4 2016 Portfolio in Review
As of Q4 2016, Granite Point Capital Management held 112 positions worth $125M, down 51% from $256M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Granite Point Capital Management withdrew a net $122M in Q4 2016, closing 32 positions and reducing 8 holdings. Its most notable exit was Apple, an estimated $4.91M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Granite Point Capital Management opened a new position in Alnylam Pharmaceuticals worth $4.12M.
- Granite Point Capital Management's largest Q4 2016 buy was Alnylam Pharmaceuticals: 110,000 shares worth $4.12M.
- Granite Point Capital Management added most to Axogen in Q4 2016, an estimated $2.46M increase.
- Granite Point Capital Management's biggest Q4 2016 reduction was Sarepta Therapeutics, cutting an estimated $4.02M.
- Granite Point Capital Management fully exited Apple in Q4 2016, selling an estimated $4.91M.
- Granite Point Capital Management's ten largest holdings make up 39% of its $125M portfolio in Q4 2016.
- Granite Point Capital Management opened 21 new positions and closed 32 in Q4 2016.
- Granite Point Capital Management's portfolio value fell 51% quarter-over-quarter to $125M.
Based on Granite Point Capital Management's 13F filing for Q4 2016, filed 7 Feb 2017.